News
Thirona’s artery-vein and segment segmentation helps in lung cancer surgeries
A new paper has just been published in high-impact journal JTCVS Techniques, showing the added value of AI-based lung segmentation and VR technology in lung cancer surgery planning. In the study from Erasmus Medical Center, Thirona's lung CT segmentation was visualized in a 3D virtual reality environment from MedicalVR for planning complex lung segmentectomies.
Thirona launches AI software for Cystic Fibrosis
Thirona developed an AI algorithm that revolutionizes cystic fibrosis (CF) care. The new algorithm, coined PRAGMA-AI, allows for fast, automated analysis of CT scans of patients with CF to detect and quantify lung abnormalities related to CF. These quantifications are critical in determining the status of the patient and determine optimal treatment paths but are not feasible to be performed by humans in clinical care. The release of PRAGMA-AI paves the way for large-scale usage in clinical trials and clinical care for better diagnostics, patient monitoring, and treatment planning.
LUMC calculates lung damages COVID-19 patients with AI technology
Healthcare professionals at Leiden University Medical Centre (LUMC) can use artificial intelligence (AI) to quickly and easily calculate whether a corona patient has suffered serious lung damage. They do this by running a CT scan through the AI software CAD4COVID-CT. The software was developed by the company Thirona and is used in the LUMC via Philips Intellispace AI Workflow Suite.
What we do
Clinical Care
Artificial intelligence can play a substantial role in clinical care. To aid medical specialists in their daily tasks, we develop software products focusing on the analysis of thoracic CT scans, chest X-rays, and retinal images. Our automated analysis solutions are used across the globe for clinical decision making, patient monitoring, treatment planning, and screening.
Clinical Trials & Research
Our deep learning based analysis tools are extensively used in pharmacological and biotechnological trials. Sophisticated quantitative measures for lung diseases like COPD, Asthma, Cystic Fibrosis, ILD and COVID-19 provide valuable insights into disease progression and drug response. Thirona is also actively involved in the academic community and provides quantitative image assessment in numerous academic studies.
Solutions
Artificial intelligence for analysis of chest X-ray images
CAD4TB is a computer-aided detection system that can detect tuberculosis-related abnormalities in posterior-anterior chest X-rays.
Artificial Intelligence for analysis of retina images
RetCAD is a computer-aided detection system that detects abnormalities related to Age-related Macular Degeneration (AMD) and Diabetic Retinopathy (DR).
Certified image analysis service
Thirona offers quantitative image analysis through ISO 13485-certified Image Analysis Service to ensure high-quality results.
